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With the recent publication of the complete sequence of the
Plasmodium falciparum chromosome 2, an additional step to-
wards the understanding of the biology of this important hu-
man pathogen has been made [1]. Hopefully, the genome se-
quence will provide a basis for further study and the possible
identi¢cation of targets for drug and vaccine development.
This project follows the model of eukaryotic genome sequenc-
ing, one complete chromosomal sequence at a time, which was
initiated with the yeast chromosome III [2,3]. Progress has
been made by developing systems that perform automated
genome sequence annotation and can further accelerate the
experimental analysis [4]. Yet, computational genomics still
depend on the insight of the analysis teams and loosely used
terminology, despite the fact that biological research requires
strict protocols and method speci¢cations.
1. The question of reproducibility
A reason for this discrepancy comes from the fact that the
computational analysis of genome sequences is still largely an
imprecise process and occasionally non-reproducible [5].
Although automated genome sequence annotation systems
o¡er reproducibility of results and clear speci¢cations of the
criteria employed [6], they have been regarded as inadequate
for some purposes [7]. The end result today is a vast collection
of genome sequence annotations by various groups (for 20
complete, and many partial, genomes at the time of writing1)
that may be con£icting or inconsistent and usually impossible
to compare.
By its very nature, the crucial step of genome annotation
should be carried out with the utmost precision and clarity [8].
Any genome sequence annotation project should be repro-
ducible and well-documented. To achieve this, accurate pro-
cedures and protocols as well as adequate representational
devices are required [9]. Until this goal is reached, it is
compelling that genome annotation groups should be ex-
tremely cautious in making their results clear, publicly avail-
able and, at the very least, reproducible.
2. Comparing notes
Currently, there is a general lack of comparative studies for
di¡erent annotation projects. Although it is well-known
(and expected) that di¡erences may exist, there is no quanti-
¢cation of the degree of con£ict between various analysis
projects. One exception is the genome of Methanococcus jan-
naschii, which is being continually annotated over a period of
3 years2. That comparison showed that there can be a level of
con£ict as high as 10% between di¡erent groups and meth-
odological approaches [10]. To examine the recent results for
the P. falciparum chromosome 2, we have performed an anal-
ysis of the 210 gene sequences, employing methods identical to
those reported in the original publication3 [1].
3. The P. falciparum chromosome 2
Our e¡orts have yielded strikingly di¡erent results for the
P. falciparum chromosome 2 sequence. It is surprising that
despite the virtual absence of false positives, only 124 out of
210 (59%) cases are in general agreement (Fig. 1). The ambi-
tion for high coverage in the original analysis appears both to
compromise clarity and render a comparison very di⁄cult [1].
We list below some major categories of cases where annota-
tion can be misleading and we identify the sources of con£ict
and provide some recommendations.
(1) We have observed seven cases where the presence of a
domain was used for the annotation of the entire sequence.
For instance, the C-terminal domain of PFB0520w displays
similarities to serine/threonine kinases, while its N-terminal
domain remains unique. This open reading frame has been
described as a ‘novel prt kinase’ by the original authors [1].
Functional descriptions should only be accepted if homology
covers the full length of the query sequence. Otherwise, do-
main similarity should be clearly stated in the annotation
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 5 9 9 - 2
*Corresponding author. Fax: (44) (1223) 494471.
E-mail: ouzounis@ebi.ac.uk
1 http://geta.life.uiuc.edu/~nikos/genomes.html, mirrorred at:
http://www.ebi.ac.uk/research/cgg/genomes.html
2 http://geta.life.uiuc.edu/~nikos/MJannotations.html, mirrorred at:
http://www.ebi.ac.uk/research/cgg/annotation/MJannotations.html.
3 BLAST(p) version 1.4.8, 2.0 and psi-BLAST against the non-redun-
dant protein sequence database (nrdb) at the EBI (version 23 Febru-
ary 1999 with 374 547 sequences and 111 115 040 residues): a new
method of compositional bias masking called CAST ([6], Promponas
et al., in preparation) was used. Only similarity-based prediction
methods were employed in the present study.
FEBS 22059 25-5-99
FEBS 22059FEBS Letters 451 (1999) 354^355
(a working de¢nition here could be that a domain is present
when the similar sequence covers less than half the length of
the query sequence).
(2) It is important to unambiguously distinguish similarity-
based from ‘ab initio’ predictions as well as to provide the
source of annotation for all query sequences characterised by
similarity. Examples are PFB0125c and PFB0980w, both of
which have been originally described as ‘predicted membrane-
associated prt’ [1] : PFB0125c is unique in the database, while
PFB0980w is similar to PFB0085c, PFB0920w and PFB0925w
(which in turn have been correctly characterised as ‘prt with
DnaJ domain (RESA-like)’ [1]). Two additional problems
with the ‘ab initio’ predictions are that the accuracy of the
programs employed is not discussed and the terms used (‘OO’,
‘TM’, ‘membrane-associated’ versus ‘integral membrane prt’)
are not explicitly de¢ned [1]. These annotations are incorpo-
rated into the public databases and become a potential source
of error propagation. We have seen nine cases that are ‘pre-
dicted’ to be membrane/secreted proteins or enzymes (Fig. 1).
(3) For the cases where functional prediction is not possible,
it is necessary to specify whether they have no detectable
homologues in the database (with a speci¢ed cut-o¡ score
and pairwise sequence comparison methods, de¢ned as
unique) or exhibit similarities to proteins of unknown func-
tion (usually described as hypothetical). This simple naming
convention has been proven useful in distinguishing between
species-speci¢c and ubiquitous genes [4]. The authors report
that 43% of the genes have no detectable homologues, but this
number is virtually unobtainable. Some non-similarity-based
predictions can also be found in this category (for example,
PFB0780c which we report as a hypothetical protein with
similarity to PFB0770c, has been originally described as ‘pre-
dicted integral membrane prt’ [1]). In total, we have observed
65 cases that have not been properly annotated as ‘unique’
sequences in the database (Fig. 1).
(4) Finally, we were unable to trace the source of the assign-
ment for ¢ve cases. These can be considered as non-repro-
ducible. Although some of these cases may be false positives,
it is not possible to classify them in any of the above men-
tioned categories and they can only be taken as con£icting
annotations. One example is PFB0535w (similar to vanadate
resistance proteins, originally characterised as ‘predicted
multiple TM membrane prt’, without an indication for the
source of this assignment [1]).
Even if the 65 cases mentioned under case (3) are consid-
ered as agreeing in principle, the 21 remaining cases would
represent exactly 10% of the total number of genes analysed.
It is worth asking whether it is of any value to risk over-
predictions and/or non-reproducible results for such a number
of additional predictions or refrain from any annotation to
avoid such con£icts.
4. Concluding recommendations
When results are not readily reproducible, it may be wise to
neglect terms such as ‘hypothetical’, ‘predicted’ or other, very
poor, predictions altogether. An alternative is to use these
terms in a consistent manner, as is done in SWISS-PROT
(Rolf Apweiler, personal communication). As more computa-
tional biology groups collaborate with primary genome se-
quencing centres, the strategies for the deposition of the
data should be reconsidered. In the past, the de¢nitions of
most sequence records in the database were derived from ex-
perimental analysis, while the same ¢elds today are used for
computational predictions.
This comparative study underlines the subjective nature of
the sequence annotation process. It is imperative that anno-
tators strive for high precision, re-use of similar terms, clarity
of de¢nitions and reproducibility of results [11]. A conserva-
tive approach to genome sequence annotation may indeed
form a ¢rst step towards speci¢cations of restricted vocabula-
ries for the description of the molecular function.
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Fig. 1. Distribution of agreement for the sequence annotations of
the P. falciparum chromosome 2 sequence. Of the 210 total gene se-
quences, 124 were in agreement between the original and the current
analysis. There are 65 proteins that are unique in the database but
not annotated as such, nine proteins that were not characterised as
‘hypothetical’ (with homologues of unknown function), seven pro-
teins that were characterised on the basis of the presence of a do-
main only and ¢nally, ¢ve cases that cannot be classi¢ed in any of
the above categories. A table containing detailed information is
available at Ghttp://www.ebi.ac.uk/research/cgg/annotation/pf2.htmlf.
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